RGNX
Regenxbio Inc
NASDAQ: RGNX · HEALTHCARE · BIOTECHNOLOGY
$8.97
+6.79% today
Updated 2026-04-30
Market cap
$452.17M
P/E ratio
—
P/S ratio
2.65x
EPS (TTM)
$-3.76
Dividend yield
—
52W range
$7 – $16
Volume
0.8M
Regenxbio Inc (RGNX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |